Mersana Therapeutics, Inc.·4

Sep 7, 5:53 PM ET

MISRA TUSHAR 4

4 · Mersana Therapeutics, Inc. · Filed Sep 7, 2023

Insider Transaction Report

Form 4
Period: 2023-09-05
MISRA TUSHAR
Chief Manufacturing Officer
Transactions
  • Award

    Restricted stock unit

    2023-09-05+50,00050,000 total
    Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the Issuer.
  • [F2]The RSUs will vest on October 1, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date.

Documents

1 file
  • 4
    tm2325674-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT